Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Funds / AH Bio Fund Iii-Q, L.P.

AH Bio Fund Iii-Q, L.P.

MatureClosed to new capitalFundADV: Venture Capital FundAndreessen HorowitzDelaware
Amounts, each with its basis
Vintage
2020basis: form d first sale
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
$60.8Mwhat may be sold, not what was raised; file 021-360599, sworn by the adviser or filed under this vehicle
Form D sold
$60.8Mas of the filing of Feb 14, 2020, 34 investors
First sale
Jan 31, 2020
Reported GAV
$101Mon the Form ADV filed Mar 29, 2024; the fund's assets, never its size or dry powder
Owners (ADV)
41
Reported on ADV
Mar 30, 2021 to Mar 29, 2024
Fundraising evidence
Closed to new capital
Form D filed or amended 2020-02-14: the stated $60.8M offering reported fully sold (fr-1)
evidence dated Feb 14, 2020. A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Mature
vintage 4 to 7 years
age years: 6first sale: 2020-01-31vintage year: $2,020adv gav as of: 2024-03-29vintage basis: form_d_first_saleform d sold usd: $60.8Mform d offering usd: $60.8Mform d latest filed at: 2020-02-14
The fund's own reporting through time
8 Form ADV filings
FiledTypeGross asset value OwnersMin. investmentAdviser-ownedAudit
Mar 30, 2021Venture Capital Fund$78.8M
410%yes
Feb 28, 2022Venture Capital Fund$78.8M
410%yes
Mar 29, 2022Venture Capital Fund$96.9M
410%yes
May 6, 2022Venture Capital Fund$96.9M
410%yes
Mar 31, 2023Venture Capital Fund$95.1M
420%yes
Mar 31, 2023Venture Capital Fund$95.1M
420%yes
May 1, 2023Venture Capital Fund$95.1M
420%yes
Mar 29, 2024Venture Capital Fund$101M
412%yes
Principals and agents
2 principals on Form D, 0 placement agents
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
3 events
  1. Mar 30, 2021
    AH Bio Fund Iii-Q, L.P. first reported on Form ADV by Andreessen Horowitz (Venture Capital Fund), GAV $78,779,573
    Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Mar 3, 2020
    AH Bio Fund III-Q, L.P. filed Form D/A: $75,000,000 sold of $75,000,000, Venture Capital Fund
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  3. Feb 14, 2020
    AH Bio Fund III-Q, L.P. filed Form D: $60,800,000 sold of $60,800,000, Venture Capital Fund
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
52 observations
Every observation on this vehicle